Bulletin

THE TOP HIGHLIGHTS
Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India
News Featured

Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India

Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
2 min read
UNICEF & PAHO
Accreditations & Approvals

Venus Remedies Secures Major Tenders from UNICEF and PAHO to Enhance Global Healthcare

Venus Remedies Limited, a global leader in the pharmaceutical industry, has achieved significant milestones by securing two prestigious tenders from globally renowned organizations—UNICEF and the Pan American Health Organization (PAHO). These wins mark a pivotal moment in the company's journey towards enhancing healthcare access and outcomes worldwide. UNICEF Tender
2 min read
image image image image image